The Food and Drug Administration (FDA) is taking the next step in its historic review of MDMA-assisted therapy for the treatment of post-traumatic stress disorder (PTSD), scheduling a meeting next month where an expert committee will examine the evidence behind the application. Lykos Therapeutics (formerly MAPS Public Benefit Corporation) announced on Monday that FDA’s Psychopharmacologic … Continue reading FDA Expert Committee Will Review MDMA-Assisted Therapy For PTSD Next Month